Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

Clinical trial NCT07310264 · RECRUITING

Trial details

NCT number: NCT07310264
Sponsor: Vertero Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers (HV)Parkinson's Disease (PD)

Start date: 2025-10-30
Primary completion: 2026-09-28
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.